Literature DB >> 19939913

The alpha/beta interferon receptor provides protection against influenza virus replication but is dispensable for inflammatory response signaling.

Alan G Goodman1, Hui Zeng, Sean C Proll, Xinxia Peng, Cristian Cillóniz, Victoria S Carter, Marcus J Korth, Terrence M Tumpey, Michael G Katze.   

Abstract

The innate immune response provides the first line of defense against foreign pathogens by responding to molecules that are a signature of a pathogenic infection. Certain RNA viruses, such as influenza virus, produce double-stranded RNA as an intermediate during the replication life cycle, which activates pathogen recognition receptors capable of inducing interferon production. By engaging interferon receptors, interferon activates the JAK-STAT pathway and results in the positive feedback of interferon production, amplifying the response to viral infection. To examine how deficiencies in interferon signaling affect the cellular response to infection, we performed influenza virus infections of mouse embryonic fibroblasts lacking the alpha/beta interferon receptor, the gamma interferon receptor, or both. In the absence of the alpha/beta interferon receptor, we observed increased viral replication but decreased activation of PKR, Stat1, and NF-kappaB; the presence or absence of the gamma interferon receptor did not exhibit discernible differences in these readouts. Analysis of gene expression profiles showed that while cells lacking the alpha/beta interferon receptor exhibited decreased levels of transcription of antiviral genes, genes related to inflammatory and apoptotic responses were transcribed to levels similar to those of cells containing the receptor. These results indicate that while the alpha/beta interferon receptor is needed to curb viral replication, it is dispensable for the induction of certain inflammatory and apoptotic genes. We have identified potential pathways, via interferon regulatory factor 3 (IRF3) activation or Hoxa13, Polr2a, Nr4a1, or Ing1 induction, that contribute to this redundancy. This study illustrates another way in which the host has evolved to establish several overlapping mechanisms to respond to viral infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19939913      PMCID: PMC2812385          DOI: 10.1128/JVI.01595-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Purification of influenza viral complementary RNA: its genetic content and activity in wheat germ cell-free extracts.

Authors:  P R Etkind; R M Krug
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

2.  Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon.

Authors:  E Meurs; K Chong; J Galabru; N S Thomas; I M Kerr; B R Williams; A G Hovanessian
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

3.  IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.

Authors:  Sergei V Kotenko; Grant Gallagher; Vitaliy V Baurin; Anita Lewis-Antes; Meiling Shen; Nital K Shah; Jerome A Langer; Faruk Sheikh; Harold Dickensheets; Raymond P Donnelly
Journal:  Nat Immunol       Date:  2002-12-16       Impact factor: 25.606

Review 4.  On the role of IRF in host defense.

Authors:  Betsy Barnes; Barbora Lubyova; Paula M Pitha
Journal:  J Interferon Cytokine Res       Date:  2002-01       Impact factor: 2.607

Review 5.  Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback.

Authors:  David E Levy; Isabelle Marié; Eric Smith; Arun Prakash
Journal:  J Interferon Cytokine Res       Date:  2002-01       Impact factor: 2.607

6.  c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation.

Authors:  Xiaohui Liu; Jerusalem Tesfai; Yvonne A Evrard; Sharon Y R Dent; Ernest Martinez
Journal:  J Biol Chem       Date:  2003-03-26       Impact factor: 5.157

7.  Role of nuclear factor-kappaB in the antiviral action of interferon and interferon-regulated gene expression.

Authors:  Lawrence M Pfeffer; Jong-Gwan Kim; Susan R Pfeffer; Dennis J Carrigan; Darren P Baker; Lai Wei; Ramin Homayouni
Journal:  J Biol Chem       Date:  2004-05-06       Impact factor: 5.157

8.  HOXA13 regulates the expression of bone morphogenetic proteins 2 and 7 to control distal limb morphogenesis.

Authors:  Wendy M Knosp; Virginia Scott; Hans Peter Bächinger; H Scott Stadler
Journal:  Development       Date:  2004-09       Impact factor: 6.868

9.  Requirement of histone deacetylase activity for signaling by STAT1.

Authors:  Lidija Klampfer; Jie Huang; Laurie-Anne Swaby; Leonard Augenlicht
Journal:  J Biol Chem       Date:  2004-05-03       Impact factor: 5.157

10.  Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression.

Authors:  Melanie J McConnell; Nathalie Chevallier; Windy Berkofsky-Fessler; Jena M Giltnane; Rupal B Malani; Louis M Staudt; Jonathan D Licht
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

View more
  25 in total

Review 1.  Notch system in the linkage of innate and adaptive immunity.

Authors:  Toshihiro Ito; Judith M Connett; Steven L Kunkel; Akihiro Matsukawa
Journal:  J Leukoc Biol       Date:  2012-03-29       Impact factor: 4.962

Review 2.  Innate immunity to influenza virus infection.

Authors:  Akiko Iwasaki; Padmini S Pillai
Journal:  Nat Rev Immunol       Date:  2014-05       Impact factor: 53.106

3.  Activation of innate immune responses in the central nervous system during reovirus myelitis.

Authors:  Stephanie A Schittone; Kalen R Dionne; Kenneth L Tyler; Penny Clarke
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  Virus infection rapidly activates the P58(IPK) pathway, delaying peak kinase activation to enhance viral replication.

Authors:  Alan G Goodman; Bertrand C W Tanner; Stewart T Chang; Mariano Esteban; Michael G Katze
Journal:  Virology       Date:  2011-05-25       Impact factor: 3.616

5.  Nucleic acid sensing and innate immunity: signaling pathways controlling viral pathogenesis and autoimmunity.

Authors:  Laura R H Ahlers; Alan G Goodman
Journal:  Curr Clin Microbiol Rep       Date:  2016-06-29

6.  Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection.

Authors:  Ioannis Ioannidis; Beth McNally; Meredith Willette; Mark E Peeples; Damien Chaussabel; Joan E Durbin; Octavio Ramilo; Asuncion Mejias; Emilio Flaño
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

7.  Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection.

Authors:  Gregory A Zornetzer; Matthew B Frieman; Elizabeth Rosenzweig; Marcus J Korth; Carly Page; Ralph S Baric; Michael G Katze
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

8.  A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo.

Authors:  Gina M Conenello; Jennifer R Tisoncik; Elizabeth Rosenzweig; Zsuzsanna T Varga; Peter Palese; Michael G Katze
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

9.  Enhanced production of human influenza virus in PBS-12SF cells with a reduced interferon response.

Authors:  Monica Carvajal-Yepes; Kelly R B Sporer; Jenna L Carter; Christopher J Colvin; Paul M Coussens
Journal:  Hum Vaccin Immunother       Date:  2015-06-19       Impact factor: 3.452

10.  Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge.

Authors:  Jacob E Kohlmeier; Tres Cookenham; Alan D Roberts; Shannon C Miller; David L Woodland
Journal:  Immunity       Date:  2010-07-23       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.